Belong.Life said it planned to use the funds to advance its cancer social network, which is gaining traction among global healthcare providers, payers and life science companies.
It is also investing in a new platform designed to improve patient engagement, education, compliance and satisfaction.
The funding round included The Group Ventures and existing investors.
“Belong can utilize and complement IQVIA’s solutions to transform patient engagement,” said Tal Rosenberg, senior vice president of global technology solutions at IQVIA.
Reporting by Steven Scheer; Editing by Tova CohenOur Standards: The Thomson Reuters Trust Principles.